ArticleFrontiers in oncology2025
Risk factor analysis of childhood and adolescent thyroid cancer mediastinal lymph node and distant metastasis.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of this study is to explore the risk factors related to mediastinal lymph node metastasis (MLNM) and distant metastasis (DM) in children and adolescents with thyroid cancer. Method: This is a retrospective analysis of children and adolescent thyroid cancer patients admitted to our hospital from January 2015 to October 2022. The clinical and pathological data, and the preoperative ultrasound features of the patients were statistically analyzed. Results: This study included a total of 67 patients, consisting of 20 males and 47 females. Among them, 14 cases (20.9%) had mediastinal lymph node metastasis and 21 cases (31.3%) had distant metastasis. The univariate analysis showed that gender, the central metastatic lymph node ratio (CCLNR), and DM were all correlated in MLNM. The nodule morphology, location, the CCLNR, and MLNM were identified as related factors in DM. The multivariate regression results showed that gender and DM were independent MLNM risk factors. Furthermore, the lesion morphology and the CCLNR were identified as independent DM risk factors. Conclusion: The larger the CCLNR ratio, the higher the likelihood of the development MLNM and DM in children and adolescent thyroid cancer patients. A CCLNR > 0.79 as an evaluation index can indicate that children and adolescents with thyroid cancer are at higher risk of developing MLNM and DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.